Medical Innovation Exchange

Lysogene's lead gene therapy flunks phase 2/3 trial almost a year after Sarepta walked out

https://www.fiercebiotech.com/biotech/lysogenes-lead-gene-therapy-flunks-phase-23-trial-almost-year-after-sarepta-walked-out

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!